North America Smart Inhalers Market to Reach US$ 3,749.90 Mn at a CAGR of 25.7% in 2027 | The Insight Partners

North America Smart Inhalers Market to 2027 - Regional Analysis and Forecasts by Product (Nebulizers and Inhalers); Disorder (Chronic Obstructive Pulmonary Disease (COPD), and Asthma); End User (Home-Care Settings and Hospitals & Clinics), and Country

Publication Month: Oct 2019 | Report Code: TIPRE00006805 | No. of Pages: 110 | Category: Medical Device | Status: Published

The North America smart inhalers market is expected to reach US$ 3,749.90 Mn in 2027 from US$ 503.91 Mn in 2018. The market is estimated to grow with a CAGR of 25.7% from 2019-2027.

 

The growth of the market is driven by the factors such as, growing geriatric population rising prevalence of COPD and asthma, along with rising awareness regarding the medical condition. However, the market is likely to get impacted due to risks associated with cyber threats limited knowledge regarding the use of smart inhalers.

 

The cases of asthma and COPD has been increasing across the globe at a significant rate. During recent years, there has been rise in the number of smokers as well as air pollution in developed as well as developing countries. Asthma is a non-communicable disease categorized by recurrent attacks of breathlessness and wheezing, which differ in severity and frequency from person to person. While an asthma attack occurs, the lining of the bronchial tubes swells, affecting the airways to narrow, hence limiting the flow of air into and out of the lungs. Recurrent asthma symptoms frequently lead to feeling of daytime fatigue, sleeplessness, reduced activity levels and school and work absence. As per estimates provided by the WHO, there are currently 235 million people suffering from asthma across the globe. As per the Centers for Disease Control and Prevention (CDC), the number of adults above 18 years of age currently having asthma are approximately 19 million in the United States, accounting for almost 7.7% of the total adult population.

 

Similarly, there has been rising prevalence of COPD across the North America. Chronic obstructive pulmonary disease (COPD) is a progressive fatal lung disease that leads to breathlessness, leading to predisposes then exacerbations and later causes serious illness. As per the Global Burden of Disease Study report, a prevalence of around 251 million cases of COPD were recorded globally during the year 2016. It is estimated that globally approximately 3.17 million deaths were caused due to COPD during the year 2015, accounting for almost 5% of all deaths in 2015. The prevalence of COPD has been high in developed nations during the recent years. For instance, COPD is recognized as the third leading cause of death by disease in the United States. Approximately, 11 million individual are diagnosed with COPD. Hence, the rising prevalence of respiratory conditions such as asthma and COPD is anticipated to fuel the growth of the smart inhalers market across the globe at an exponential rate.

 

US is expected to lead the market in the North America region because the US has presence of various associations which provide help in the field of lung diseases. For instance, American Lung Association conducts research activities, education and training as well as undertakes initiatives to offer better treatment and support for the patients suffering with respiratory conditions such as asthma, COPD, influenza, lung cancer, pneumonia, and pulmonary fibrosis among others. Therefore, considering the above mentioned factors the growth of the market in the country is likely to contribute largest share in the North America region during the forecast period.

 

Exhibit: Mexico Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)

 

NORTH AMERICA SMART INHALERS – MARKET SEGMENTATION

 

By Product

  • Inhalers
  • Nebulizers

 

By Disorder

  • Asthma
  • Chronic Obstructive Pulmonary Disease (COPD)

 

By End User

  • Home-care Settings
  • Hospitals & Clinics

 

By Geography

  • North America
    • US
    • Canada
    • Mexico

 

Company Profiles

  • GlaxoSmithKline plc
  • Adherium Ltd.
  • Vectura Group plc
  • Novartis AG
  • Findair Sp. z o. o.
  • Cohero Health
  • Crux Product Design Ltd
  • Teva Pharmaceuticals
  • 3M
  • Amiko Digital Health Limited

 

1.              Introduction

1.1       Scope Of The Study

1.2       The Insight Partners Research Report Guidance

2.              North America Smart Inhalers Market Market – Key Takeaways

3.              North America Smart Inhalers Market – Market Landscape

3.1       Overview

3.2       Market Segmentation

3.2.1       North America Smart Inhalers Market – By Product

3.2.2       North America Smart Inhalers Market – By Disorder

3.2.3       North America Smart Inhalers Market – By End User

3.2.4       North America Smart Inhalers Market – By North America Region

3.3       Pest Analysis

4.              North Americasmart Inhalers Market – Key Market Dynamics

4.1       Key Market Drivers

4.1.1       Increasing Levels of Air Pollution as well as Rise in the Smoking Habits

4.1.2       Rising Prevalence of Asthma and COPD Across the North America

4.1.3       Growing Geriatric Population

4.2       Key Market Restraints

4.2.1       Risks Associated with Cyber Threats

4.2.2       Limited Knowledge Regarding the Use of Smart Inhalers

4.3       Key Market Opportunity

4.3.1       Growth in the North America Healthcare Market

4.4       Future Trend

4.4.1       Increasing Acceptance of Mobile Health Technology

4.5       Impact Analysis

5.              Smart Inhalers Market – North America Analysis

5.1       North America Smart Inhalers Market Revenue Forecasts And Analysis

5.2       Performance Of Key Players

6.              Smart Inhalers Market Analysis And Forecasts To 2027 – Product

6.1       Overview

6.2       North America Smart Inhalers Market Share By PRODUCT 2018 & 2027 (%)

6.3       Inhalers Market

6.3.1       Overview

6.3.2       Inhalers Market Revenue and Forecast to 2027 (US$ Mn)

6.4       Nebulizers Market

6.4.1       Overview

6.4.2       Nebulizers Market Revenue and Forecast to 2027 (US$ Mn)

7.              Smart Inhalers Market Analysis And Forecasts To 2027 – Disorder

7.1       Overview

7.2       North America Smart Inhalers Market Share By Application 2018 & 2027 (%)

7.3       Asthma Diabetes

7.3.1       Overview

7.3.2       Asthma Market Revenue and Forecast to 2027 (US$ Mn)

7.4       CHRONIC OBSTRUCTIVE PULMONARY DISEASE Market

7.4.1       Overview

7.4.2       Chronic Obstructive Pulmonary Disease Market Revenue and Forecast to 2027 (US$ Mn)

8.              Smart Inhalers Market Analysis And Forecasts To 2027 – End User

8.1       Overview

8.2       North America Smart Inhalers Market Share By End User 2018 & 2027 (%)

8.3       Hospitals & Clinics Market

8.3.1       Overview

8.3.2       Hospitals & Clinics Market Revenue and Forecast to 2027 (US$ Mn)

8.4       Home Care Settings Market

8.4.1       Overview

8.4.2       Home-Care Settings Market Revenue and Forecast to 2027 (US$ Mn)

9.              Smart Inhalers Market Revenue And Forecasts To 2027 – North America Analysis

9.1       North America Smart Inhalers Market Revenue And Forecasts To 2027

9.1.1       North America Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.2       North America Smart Inhalers Market Revenue And Forecasts to 2027, By Product (US$ Mn)

9.1.3       North America Smart Inhalers Market Revenue And Forecasts to 2027, By Disorder (US$ Mn)

9.1.4       North America Smart Inhalers Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.1.5       North America Smart Inhalers Market Revenue And Forecasts to 2027, By Country (%)

9.1.6       US Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.6.1    US Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.6.2    US Smart Inhalers Market Revenue And Forecasts to 2027, By Product (US$ Mn)

9.1.6.3    US Smart Inhalers Market Revenue And Forecasts to 2027, By Disorder (US$ Mn)

9.1.6.4    US Smart Inhalers Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.1.7       Canada Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.7.1    Canada Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.7.2    Canada Smart Inhalers Market Revenue And Forecasts to 2027, By Product (US$ Mn)

9.1.7.3    Canada Smart Inhalers Market Revenue And Forecasts to 2027, By Disorder (US$ Mn)

9.1.7.4    Canada Smart Inhalers Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.1.8       Mexico Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.8.1    Mexico Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.8.2    Mexico Smart Inhalers Market Revenue And Forecasts to 2027, By Product (US$ Mn)

9.1.8.3    Mexico Smart Inhalers Market Revenue And Forecasts to 2027, By Disorder (US$ Mn)

9.1.8.4    Mexico Smart Inhalers Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.           Smart Inhalers Market– Industry Landscape

10.1    Overview

10.2    Comparative Company Analysis

10.3    Growth Strategies Done By The Companies In The Market, (%)

10.4    Organic Developments

10.4.1    Overview

10.5    Inorganic Developments

10.5.1    Overview

11.           Smart Inhalers Market–Key Company Profiles

11.1    Glaxosmithkline Plc.

11.1.1    Key Facts

11.1.2    Business Description

11.1.3    Financial Overview

11.1.4    Product Portfolio

11.1.5    SWOT Analysis

11.1.6    Key Developments

11.2    Adherium Limited

11.2.1    Key Facts

11.2.2    Business Description

11.2.3    Financial Overview

11.2.4    Product Portfolio

11.2.5    SWOT Analysis

11.2.6    Key Developments

11.3    Novartis AG

11.3.1    Key Facts

11.3.2    Business Description

11.3.3    Financial Overview

11.3.4    Product Portfolio

11.3.5    SWOT Analysis

11.3.6    Key Developments

11.4    Vectura Group Plc

11.4.1    Key Facts

11.4.2    Business Description

11.4.3    Financial Overview

11.4.1    Product Portfolio

11.4.2    SWOT Analysis

11.4.3    Key Developments

11.5    Cohero Health, Inc.

11.5.1    Key Facts

11.5.2    Business Description

11.5.3    Financial Overview

11.5.4    Product Portfolio

11.5.5    SWOT Analysis

11.5.6    Key Developments

11.6    Crux Product Design Ltd

11.6.1    Key Facts

11.6.2    Business Description

11.6.3    Financial Information

11.6.4    Product Portfolio

11.6.5    SWOT Analysis

11.6.6    Key Developments

11.7    Findair Sp. Z O. O.

11.7.1    Key Facts

11.7.2    Business Description

11.7.3    Financial Overview

11.7.4    Product Portfolio

11.7.5    SWOT Analysis

11.7.6    Key Developments

11.8    Teva Pharmaceutical Industries Ltd.

11.8.1    Key Facts

11.8.2    Business Description

11.8.3    Financial Overview

11.8.4    Product Portfolio

11.8.5    SWOT Analysis

11.8.6    Key Developments

11.9    3m

11.9.1    Key Facts

11.9.2    Business Description

11.9.3    Financial Overview

11.9.4    Product Portfolio

11.9.5    SWOT Analysis

11.9.6    Key Developments

11.10  Amiko Digital Health Limited

11.10.1 Key Facts

11.10.2 Business Description

11.10.3 Financial Overview

11.10.4 Product Portfolio

11.10.5 SWOT Analysis

11.10.6 Key Developments

12.           Appendix

12.1    About The Insight Partners

12.2    Glossary Of Terms

 

LIST OF TABLES

Table 1.            Total Number Of Persons Aged 60 Years Or Above In North America, 2017 & 2050

Table 2.            North America Smart Inhalers Market Revenue And Forecasts To 2027, By Product (US$ Mn)

Table 3.            North America Smart Inhalers Market Revenue And Forecasts To 2027, By Disorder (US$ Mn)

Table 4.            North America Smart Inhalers Market Revenue And Forecasts To 2027, By End User (US$ Mn)

Table 5.            US Smart Inhalers Market Revenue And Forecasts To 2027, By Product (US$ Mn)

Table 6.            US Smart Inhalers Market Revenue And Forecasts To 2027, By Disorder (US$ Mn)

Table 7.            US Smart Inhalers Market Revenue And Forecasts To 2027, By End User (US$ Mn)

Table 8.            Canada Smart Inhalers Market Revenue And Forecasts To 2027, By Product (US$ Mn)

Table 9.            Canada Smart Inhalers Market Revenue And Forecasts To 2027, By Disorder (US$ Mn)

Table 10.         Canada Smart Inhalers Market Revenue And Forecasts To 2027, By End User (US$ Mn)

Table 11.         Mexico Smart Inhalers Market Revenue And Forecasts To 2027, By Product (US$ Mn)

Table 12.         Mexico Smart Inhalers Market Revenue And Forecasts To 2027, By Disorder (US$ Mn)

Table 13.         Mexico Smart Inhalers Market Revenue And Forecasts To 2027, By End User (US$ Mn)

Table 14.         Organic Developments Done By Companies

Table 15.         Inorganic Developments Done By Companies

Table 16.         Glossary Of Terms, Smart Inhalers Market

 

LIST OF FIGURES

Figure 1.          US Smart Inhalers Market, Revenue (US$ Mn), 2018 & 2027

Figure 2.          North America Smart Inhalers Market By Product, Market Share (%), 2018

Figure 3.          North America Smart Inhalers Market By Disorder, Market Share (%), 2018

Figure 4.          North America Smart Inhalerss Market By End User, Market Share (%), 2018

Figure 5.          Smart Inhalers Market Segmentation

Figure 6.          Smart Inhalers Market Segmentation, By Region

Figure 7.          North America Pest Analysis

Figure 8.          North America Smart Inhalers Market Impact Analysis Of Driver And Restraints

Figure 9.          North America Smart Inhalers Market – Revenue Forecasts And Analysis –2018- 2027

Figure 10.       Market Positioning Of Key Player In North America Smart Inhalers Market

Figure 11.       North America Smart Inhalers Market Share By Product 2018 & 2027 (%)

Figure 12.       Inhalers Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 13.       Nebulizers Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 14.       North America Smart Inhalers Market Share By Application 2018 & 2027 (%)

Figure 15.       Asthma Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 16.       Chronic Obstructive Pulmonary Disease Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 17.       North America Smart Inhalers Market Share By End User 2018 & 2027 (%)

Figure 18.       Hospitals & Clinics Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 19.       Home-Care Settings Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 20.       North America Smart Inhalers Market REVENUE Overview, By Country, 2018 (US$ MN)

Figure 21.       North America Smart Inhalers Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 22.       North America Smart Inhalers Market Revenue And Forecasts To 2027, By Country (%)

Figure 23.       US Smart Inhalers Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 24.       Canada Smart Inhalers Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 25.       Mexico Smart Inhalers Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 26.       Comparative Company Analysis

Figure 27.       Growth Strategies Done By The Companies In The Market, (%)

The List of Companies

  1. GlaxoSmithKline plc
  2. Adherium Ltd.
  3. Vectura Group plc
  4. Novartis AG
  5. Findair Sp. z o. o.
  6. Cohero Health
  7. Crux Product Design Ltd
  8. Teva Pharmaceuticals
  9. 3M
  10. Amiko Digital Health Limited

 

 

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America smart inhalers market.

 

  • Highlights key business priorities in order to assist companies to realign their business strategies.

 

  • The key findings and recommendations highlight crucial progressive industry trends in the North America smarts inhaler Market, thereby allowing players across the value chain to develop effective long-term strategies.

 

  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

 

  • Scrutinize in-depth the North America market trends and outlook coupled with the factors driving the market, as well as those hindering it.

 

  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.